ESR1 and breast carcinoma: Silencing ER-α blocked the proliferative effect of 27OHC, in line with evidence suggesting a role for cholesterol metabolites in promoting the growth of ER-α-positive breast cancers through acting as endogenous SERMS [3,19,20].